22.12.2024, 2132 Zeichen
Marinomed: The majority of shareholders of Marinomed approved the sale of the Carragelose business unit to the French company Unither Pharmaceuticals at today's extraordinary general meeting. This approval is an important prerequisite for the closing of the transaction. In November 2024, Marinomed signed an agreement on the sale of the Carragelose business, which provides for upfront and milestone payments of in total up to EUR 20 million. Closing of the deal is still subject to other conditions such as approval in accordance with the Investment Control Act. “The shareholders' approval of the sale of the Carragelose business is essential for the Company's continued existence. Our strategic focus is clearly on the commercialization of the Marinosolv products Budesolv and Tacrosolv and the expansion of the Solv4U service offering. We thank our shareholders for their support and are working hard to lead the Company to profitability,” says Andreas Grassauer, CEO of Marinomed.
Marinomed Biotech: weekly performance:
Valneva: Austrian/French Valneva, a specialty vaccine company, and Serum Institute of India (SII), the world’s largest manufacturer of vaccines by number of doses, today announced an exclusive license agreement for Valneva’s single-shot chikungunya vaccine that enables supply of the vaccine in Asia. The collaboration to support broader access to the vaccine in low-and-middle-income countries (LMICs) in the region falls within the framework of the $41.3 million funding agreement Valneva signed with the Coalition for Epidemic Preparedness Innovations (CEPI) in July 2024 with co-funding from the European Union. The companies will work urgently to bring the vaccine to the Indian market, and certain other Asian countries, subject to local regulatory approvals, as India is currently enduring one of its worst chikungunya outbreaks. Nearly 370,000 cases were confirmed in India between January 2019 and July 2024, a number rapidly increasing due to the current outbreak(2) .
Valneva: weekly performance:
(From the 21st Austria weekly https://www.boerse-social.com/21staustria (19/12/2024)
Wiener Börse Party #838: ATX zum Wochenstart etwas fester, Steyr Motors bedeutet Wiener Börse Neuland, 34 PIR-Partner 2025
Aktien auf dem Radar:Amag, Palfinger, RBI, Pierer Mobility, Austriacard Holdings AG, UBM, EuroTeleSites AG, Semperit, FACC, OMV, Telekom Austria, Rosenbauer, Rosgix, Addiko Bank, AT&S, Cleen Energy, Gurktaler AG Stamm, Kapsch TrafficCom, RHI Magnesita, Flughafen Wien, Oberbank AG Stamm, Agrana, EVN, Österreichische Post, Uniqa, VIG.
Immofinanz
Die Immofinanz ist ein börsenotierter gewerblicher Immobilienkonzern, der seine Aktivitäten auf die Segmente Einzelhandel und Büro in sieben Kernmärkten in Europa (Österreich, Deutschland, Tschechien, Slowakei, Ungarn, Rumänien und Polen) fokussiert. Zum Kerngeschäft zählen die Bewirtschaftung und die Entwicklung von Immobilien.
>> Besuchen Sie 68 weitere Partner auf boerse-social.com/partner
Die Useletter "Morning Xpresso" und "Evening Xtrakt" heben sich deutlich von den gängigen Newslettern ab.
Beispiele ansehen bzw. kostenfrei anmelden. Wichtige Börse-Infos garantiert.
Newsletter abonnieren
Infos über neue Financial Literacy Audio Files für die Runplugged App
(kostenfrei downloaden über http://runplugged.com/spreadit)
per Newsletter erhalten